Equities

Akso Health Group

Akso Health Group

Actions
  • Price (EUR)0.79
  • Today's Change0.045 / 6.04%
  • Shares traded--
  • 1 Year change-17.71%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments857.9218
Total Receivables, Net09.2320
Total Inventory0.191.697.80
Prepaid expenses570.270.18
Other current assets, total01.3516
Total current assets1422063
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets1422063
LIABILITIES
Accounts payable------
Accrued expenses1.100.940.23
Notes payable/short-term debt2.009.6937
Current portion long-term debt/capital leases------
Other current liabilities, total0.491.0013
Total current liabilities3.591251
Total long term debt000
Total debt2.009.6937
Deferred income tax------
Minority interest0.060.110.00
Other liabilities, total------
Total liabilities3.651251
SHAREHOLDERS EQUITY
Common stock0.040.010.01
Additional paid-in capital2107171
Retained earnings (accumulated deficit)(64)(54)(53)
Treasury stock - common(3.99)(3.99)(3.99)
Unrealized gain (loss)------
Other equity, total(4.09)(3.85)(1.65)
Total equity1388.7312
Total liabilities & shareholders' equity1422063
Total common shares outstanding------
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.